This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Essential Hypertension
and you are
between 20 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate drug-drug interaction between fimasartan and hydrochlorothiazide.

Provided treatments

  • Drug: Fimasartan
  • Drug: Hydrochlorothiazide
Tris trial is registered with FDA with number: NCT00923533. The sponsor of the trial is Boryung Pharmaceutical Co., Ltd and it is looking for 34 volunteers for the current phase.
Official trial title:
An Open-label, Multiple-dosing, Crossover, and Parallel Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers